| Manufacturer ▼ | Drug Name | Indication | Stage | Status | Route of Administration | Drug Class |
|---|---|---|---|---|---|---|
| Biohaven Ltd. | BHV-7000 | Major Depressive Disorder | Phase 2 | Data Released | Oral | Psychiatric |
| Biohaven Ltd. | Nurtec ODT (rimegepant) | Refractory trigeminal neuralgia | Phase 2 | Trial Completed | Oral | Neurology |
| Biohaven Ltd. | Oral Zavegepant | Migraine | Phase 2/3 | Trial Completed | Oral | Neurology |
| Biohaven Ltd. | Troriluzole | Obsessive compulsive disorder (OCD) | Phase 3 | Ongoing | Oral | Psychiatric |
| Biohaven Ltd. | Taldefgrobep alfa | Obesity | Phase 2 | Ongoing | Intramuscular | Endocrinology |
| Biohaven Ltd. | Troriluzole | Alzheimer’s disease | Phase 2 | Trial Discontinued | Oral | Neurology |
| Biohaven Ltd. | BHV-8000 | Early Alzheimer's disease | Phase 2/3 | Ongoing | Oral | Neurology |
| Biohaven Ltd. | BHV-1400 | IgA Nephropathy (IgAN) | Phase 3 | Trial Planned | Oral | Immunology |